Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prima Temp
AddedFeb 15, 2024
UpdatedJun 18, 2026
Prima Temp

Prima Temp

Prima Temp: A med-tech firm specializing in fertility, early disease detection, and rhythm monitoring.

HQ
Boulder, CO, US
Founded
2010
Overview
Compare
Fundraising
Employees

Prima Temp is a medical technology company specializing in fertility detection, early disease detection, and circadian rhythm monitoring. Its platform provides alerts and information to users and healthcare providers, enhancing human physiology applications. Prima Temp has achieved significant advancements in medical technology, contributing to improved health outcomes.

Their innovative solutions have garnered attention and support from the healthcare community, positioning them as leaders in their specialized fields.

Prima Temp - Similar Companies

OVATEMP logo

OVATEMP

Praesidium logo

Praesidium

biofi.tech

BioscanR logo

BioscanR

Cyrcadia logo

Cyrcadia

cyrcadiahealth.com

Primaira logo

Primaira

primaira.com

Thermodata logo

Thermodata

PranaQ logo

PranaQ

pranaq.com

BluDiagnostics logo

BluDiagnostics

Prima logo

Prima

prima.co

Clinicai logo

Clinicai

Reproductive Research Technologies logo

Reproductive Research Technologies

Physia logo

Physia

Primo Medical Group logo

Primo Medical Group

Pulsewave logo

Pulsewave

Precision Theranostics logo

Precision Theranostics

Prima Temp - Quick Facts

Who are Prima Temp's competitors?

Companies similar to Prima Temp include OVATEMP, Praesidium, BioscanR and Cyrcadia.

When was Prima Temp founded?

Prima Temp was founded in 2010.

Where is Prima Temp's headquarters located?

Prima Temp's headquarters is located in Boulder, CO, US.

When was Prima Temp's last funding round?

Prima Temp's most recent funding round was for $6.7M (USD) in September 2017.

How much has Prima Temp raised to-date?

As of Sep 1, 2017, Prima Temp has raised a total of $11.9M (USD).

How many employees does Prima Temp have?

Prima Temp has 12 employees as of Feb 5, 2024.

Prima Temp - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Health Monitoring
  • Medical Devices
Tags
  • Biotech
  • Data Information
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified